A detailed history of Everett Harris & CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Everett Harris & CO holds 170,156 shares of EW stock, worth $15.6 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
170,156
Previous 170,241 0.05%
Holding current value
$15.6 Million
Previous $13 Million 25.27%
% of portfolio
0.22%
Previous 0.19%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$72.54 - $95.56 $6,165 - $8,122
-85 Reduced 0.05%
170,156 $16.3 Million
Q4 2023

Jan 18, 2024

SELL
$61.71 - $77.76 $41,839 - $52,721
-678 Reduced 0.4%
170,241 $13 Million
Q3 2023

Oct 23, 2023

BUY
$69.28 - $93.38 $288,274 - $388,554
4,161 Added 2.5%
170,919 $11.8 Million
Q2 2023

Jul 26, 2023

SELL
$81.41 - $94.33 $495,786 - $574,469
-6,090 Reduced 3.52%
166,758 $15.7 Million
Q1 2023

Apr 24, 2023

SELL
$74.26 - $84.51 $1.09 Million - $1.24 Million
-14,675 Reduced 7.83%
172,848 $14.3 Million
Q4 2022

Jan 20, 2023

BUY
$68.3 - $87.44 $38,589 - $49,403
565 Added 0.3%
187,523 $0
Q3 2022

Oct 21, 2022

SELL
$82.37 - $107.29 $8,813 - $11,480
-107 Reduced 0.06%
186,958 $15.4 Million
Q2 2022

Jul 22, 2022

BUY
$86.5 - $128.27 $35,292 - $52,334
408 Added 0.22%
187,065 $17.8 Million
Q1 2022

Apr 22, 2022

SELL
$101.96 - $128.34 $7,137 - $8,983
-70 Reduced 0.04%
186,657 $22 Million
Q4 2021

Feb 02, 2022

SELL
$106.37 - $130.68 $36,697 - $45,084
-345 Reduced 0.18%
186,727 $24.2 Million
Q3 2021

Nov 03, 2021

SELL
$102.91 - $122.75 $5,145 - $6,137
-50 Reduced 0.03%
187,072 $21.2 Million
Q2 2021

Jul 29, 2021

SELL
$83.84 - $104.76 $314,903 - $393,478
-3,756 Reduced 1.97%
187,122 $19.4 Million
Q4 2020

Feb 04, 2021

BUY
$71.69 - $91.23 $41,580 - $52,913
580 Added 0.3%
190,878 $17.4 Million
Q3 2020

Nov 03, 2020

BUY
$67.19 - $87.44 $99,105 - $128,974
1,475 Added 0.78%
190,298 $15.2 Million
Q2 2020

Jul 29, 2020

BUY
$57.54 - $76.95 $7.24 Million - $9.68 Million
125,845 Added 199.82%
188,823 $13.1 Million
Q1 2020

Apr 29, 2020

SELL
$52.41 - $81.0 $3 Million - $4.64 Million
-57,318 Closed
0 $0
Q4 2019

Jan 27, 2020

SELL
$71.7 - $82.09 $7,528 - $8,619
-105 Reduced 0.18%
57,318 $13.4 Million
Q3 2019

Nov 06, 2019

BUY
$61.55 - $75.43 $4,616 - $5,657
75 Added 0.13%
57,423 $12.6 Million
Q2 2019

Aug 13, 2019

BUY
$55.74 - $64.41 $9,475 - $10,949
170 Added 0.3%
57,348 $10.6 Million
Q1 2019

May 13, 2019

SELL
$47.89 - $64.05 $480,097 - $642,101
-10,025 Reduced 14.92%
57,178 $10.9 Million
Q2 2018

Jul 27, 2018

SELL
$42.45 - $51.3 $3,183 - $3,847
-75 Reduced 0.11%
67,203 $9.78 Million
Q1 2018

Apr 20, 2018

BUY
$37.19 - $47.45 $489,048 - $623,967
13,150 Added 24.29%
67,278 $9.39 Million
Q4 2017

Feb 01, 2018

SELL
$33.79 - $39.39 $844 - $984
-25 Reduced 0.05%
54,128 $6.1 Million
Q3 2017

Oct 11, 2017

BUY
$36.29 - $38.83 $1.97 Million - $2.1 Million
54,153
54,153 $5.92 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $56.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Everett Harris & CO Portfolio

Follow Everett Harris & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.